과제정보
This research was supported by Basic Science Research program through the National Research Foundation Korea Funded by the Ministry of Education, Science and Technology (NRF-2018R1D1A1A02050495 and NRF-2021R1A2C1014399).
참고문헌
- Bakowski, M. T. (1984) Advances in anti-emetic therapy. Cancer Treat. Rev. 11, 237-256. https://doi.org/10.1016/0305-7372(84)90010-0
- Barone, J. A. (1999) Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann. Pharmacother. 33, 429-440. https://doi.org/10.1345/aph.18003
- Bertram, J. S. (2000) The molecular biology of cancer. Mol. Aspects Med. 21, 167-223. https://doi.org/10.1016/S0098-2997(00)00007-8
- Budihardjo, I., Oliver, H., Lutter, M., Luo, X. and Wang, X. (1999) Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15, 269-290. https://doi.org/10.1146/annurev.cellbio.15.1.269
- Cleator, S., Heller, W. and Coombes, R. C. (2007) Triple-negative breast cancer: therapeutic options. Lancet Oncol. 8, 235-244. https://doi.org/10.1016/S1470-2045(07)70074-8
- Dalton, S. O., Mellemkjaer, L., Thomassen, L., Mortensen, P. B. and Johansen, C. (2005) Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993. Schizophr. Res. 75, 315-324. https://doi.org/10.1016/j.schres.2004.11.009
- Dent, R. A., Lindeman, G. J., Clemons, M., Wildiers, H., Chan, A., McCarthy, N. J., Singer, C. F., Lowe, E. S., Watkins, C. L. and Carmichael, J. (2013) Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer. Breast Cancer Res. 15, R88.
- Driscoll, J. S., Melnick, N. R., Quinn, F. R., Lomax, N., Davignon, J. P., Ing, R., Abott, B. J., Congleton, G. and Dudeck, L. (1978) Psychotropic drugs as potential antitumor agents: a selective screening study. Cancer Treat. Rep. 62, 45-74.
- Driver, J. A., Logroscino, G., Buring, J. E., Gaziano, J. M. and Kurth, T. (2007) A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol. Biomarkers Prev. 16, 1260-1265. https://doi.org/10.1158/1055-9965.EPI-07-0038
- Fragen, R. J. and Caldwell, N. (1978) A new benzimidazole antiemetic, domperidone, for the treatment of postoperative nausea and vomiting. Anesthesiology 49, 289-290. https://doi.org/10.1097/00000542-197810000-00015
- Gholipour, N., Ohradanova-Repic, A. and Ahangari, G. (2018) A novel report of MiR-4301 induces cell apoptosis by negatively regulating DRD2 expression in human breast cancer cells. J. Cell. Biochem. 119, 6408-6417. https://doi.org/10.1002/jcb.26577
- Golemis, E. A., Scheet, P., Beck, T. N., Scolnick, E. M., Hunter, D. J., Hawk, E. and Hopkins, N. (2018) Molecular mechanisms of the preventable causes of cancer in the United States. Genes Dev. 32, 868-902. https://doi.org/10.1101/gad.314849.118
- Jacobs, A. T., Martinez Castaneda-Cruz, D., Rose, M. M. and Connelly, L. (2022) Targeted therapy for breast cancer: An overview of drug classes and outcomes. Biochem. Pharmacol. 204, 115209.
- Kang, D. Y., Sp, N., Kim, D. H., Joung, Y. H., Lee, H. G., Park, Y. M. and Yang, Y. M. (2018) Salidroside inhibits migration, invasion and angiogenesis of MDA-MB 231 TNBC cells by regulating EGFR/Jak2/STAT3 signaling via MMP2. Int. J. Oncol. 53, 877-885. https://doi.org/10.3892/ijo.2018.4430
- Kang, Y. J., Kwon, Y. H., Jang, J. Y., Lee, J. H., Lee, S., Park, Y., Moon, H. R., Chung, H. Y. and Kim, N. D. (2023) MHY2251, a new SIRT1 inhibitor, induces apoptosis via JNK/p53 pathway in HCT116 human colorectal cancer cells. Biomol. Ther. (Seoul) 31, 73-81. https://doi.org/10.4062/biomolther.2022.044
- Kwapisz, D. (2021) Pembrolizumab and atezolizumab in triple-negative breast cancer. Cancer Immunol. Immunother. 70, 607-617. https://doi.org/10.1007/s00262-020-02736-z
- Lee, H., Jeong, A. J. and Ye, S. K. (2019) Highlighted STAT3 as a potential drug target for cancer therapy. BMB Rep. 52, 415-423. https://doi.org/10.5483/BMBRep.2019.52.7.152
- Li, H. Z., Gao, J., Hao, X. M., Zhang, L. M. and Chen, J. T. (2014) The effects of DR2 on myocardial ischemic postconditioning and its underlying mechanisms. Zhongguo Ying Yong Sheng Li Xue Za Zhi 30, 301-305.
- Li, Y. J., Zhang, C., Martincuks, A., Herrmann, A. and Yu, H. (2023) STAT proteins in cancer: orchestration of metabolism. Nat. Rev. Cancer 23, 115-134. https://doi.org/10.1038/s41568-022-00537-3
- Livasy, C. A., Karaca, G., Nanda, R., Tretiakova, M. S., Olopade, O. I., Moore, D. T. and Perou, C. M. (2006) Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod. Pathol. 19, 264-271. https://doi.org/10.1038/modpathol.3800528
- Lopez-Sanchez, L. M., Jimenez, C., Valverde, A., Hernandez, V., Penarando, J., Martinez, A., Lopez-Pedrera, C., Munoz-Castaneda, J. R., De la Haba-Rodriguez, J. R., Aranda, E. and Rodriguez-Ariza, A. (2014) CoCl2, a mimic of hypoxia, induces formation of polyploid giant cells with stem characteristics in colon cancer. PLoS One 9, e99143.
- Malik, D., Mahendiratta, S., Kaur, H. and Medhi, B. (2021) Futuristic approach to cancer treatment. Gene 805, 145906.
- Mao, M., Yu, T., Hu, J. and Hu, L. (2015) Dopamine D2 receptor blocker thioridazine induces cell death in human uterine cervical carcinoma cell line SiHa. J. Obstet. Gynaecol. Res. 41, 1240-1245. https://doi.org/10.1111/jog.12691
- Marotta, L. L., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., Wu, Z., Gonen, M., Mulvey, L. A., Bessarabova, M. O., Huh, S. J., Silver, S. J., Kim, S. Y., Park, S. Y., Lee, H. E., Anderson, K. S., Richardson, A. L., Nikolskaya, T., Nikolsky, Y., Liu, X. S., Root, D. E., Hahn, W. C., Frank, D. A. and Polyak, K. (2011) The JAK2/STAT3 signaling pathway is required for growth of CD44(+) CD24(-) stem cell-like breast cancer cells in human tumors. J. Clin. Invest. 121, 2723-2735. https://doi.org/10.1172/JCI44745
- Mengie Ayele, T., Tilahun Muche, Z., Behaile Teklemariam, A., Bogale Kassie, A. and Chekol Abebe, E. (2022) Role of JAK2/STAT3 signaling pathway in the tumorigenesis, chemotherapy resistance, and treatment of solid tumors: a systemic review. J. Inflamm. Res. 15, 1349-1364. https://doi.org/10.2147/JIR.S353489
- Mirzayans, R., Andrais, B., Scott, A., Wang, Y. W., Kumar, P. and Murray, D. (2017) Multinucleated giant cancer cells produced in response to ionizing radiation retain viability and replicate their genome. Int. J. Mol. Sci. 18, 360.
- Mu, J., Huang, W., Tan, Z., Li, M., Zhang, L., Ding, Q., Wu, X., Lu, J., Liu, Y., Dong, Q. and Xu, H. (2017) Dopamine receptor D2 is correlated with gastric cancer prognosis. Oncol. Lett. 13, 1223-1227. https://doi.org/10.3892/ol.2017.5573
- Nakayama, K., Nagahama, H., Minamishima, Y. A., Matsumoto, M., Nakamichi, I., Kitagawa, K., Shirane, M., Tsunematsu, R., Tsukiyama, T., Ishida, N., Kitagawa, M., Nakayama, K. and Hatakeyama, S. (2000) Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 19, 2069-2081. https://doi.org/10.1093/emboj/19.9.2069
- Pierce, S. R., Fang, Z., Yin, Y., West, L., Asher, M., Hao, T., Zhang, X., Tucker, K., Staley, A., Fan, Y., Sun, W., Moore, D. T., Xu, C., Tsai, Y. H., Parker, J., Prabhu, V. V., Allen, J. E., Lee, D., Zhou, C. and Bae-Jump, V. (2021) Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer. J. Exp. Clin. Cancer Res. 40, 61.
- Rascio, F., Spadaccino, F., Rocchetti, M. T., Castellano, G., Stallone, G., Netti, G. S. and Ranieri, E. (2021) The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review. Cancers (Basel) 13, 3949.
- Richa, S., Dey, P., Park, C., Yang, J., Son, J. Y., Park, J. H., Lee, S. H., Ahn, M. Y., Kim, I. S., Moon, H. R. and Kim, H. S. (2020) A new histone deacetylase inhibitor, MHY4381, induces apoptosis via generation of reactive oxygen species in human prostate cancer cells. Biomol. Ther. (Seoul) 28, 184-194. https://doi.org/10.4062/biomolther.2019.074
- Shakya, R., Park, G. H., Joo, S. H., Shim, J. H. and Choi, J. S. (2022) Hydroxyzine induces cell death in triple-negative breast cancer cells via mitochondrial superoxide and modulation of Jak2/STAT3 signaling. Biomol. Ther. (Seoul) 30, 585-592. https://doi.org/10.4062/biomolther.2022.121
- Shontz, E. C., Souders, C. L., 2nd, Schmidt, J. T. and Martyniuk, C. J. (2018) Domperidone upregulates dopamine receptor expression and stimulates locomotor activity in larval zebrafish (Danio rerio). Genes Brain Behav. 17, e12460.
- Siegel, R. L., Miller, K. D., Fuchs, H. E. and Jemal, A. (2022) Cancer statistics, 2022. CA Cancer J. Clin. 72, 7-33. https://doi.org/10.3322/caac.21708
- Stover, D. G., Gil Del Alcazar, C. R., Brock, J., Guo, H., Overmoyer, B., Balko, J., Xu, Q., Bardia, A., Tolaney, S. M., Gelman, R., Lloyd, M., Wang, Y., Xu, Y., Michor, F., Wang, V., Winer, E. P., Polyak, K. and Lin, N. U. (2018) Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer. NPJ Breast Cancer 4, 10.
- Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209-249. https://doi.org/10.3322/caac.21660
- Tegowski, M., Fan, C. and Baldwin, A. S. (2018) Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G(1) arrest independent of DRD2. J. Biol. Chem. 293, 15977-15990. https://doi.org/10.1074/jbc.RA118.003719
- Vermeulen, K., Berneman, Z. N. and Van Bockstaele, D. R. (2003) Cell cycle and apoptosis. Cell Prolif. 36, 165-175. https://doi.org/10.1046/j.1365-2184.2003.00267.x
- Wang, S. W. and Sun, Y. M. (2014) The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (review). Int. J. Oncol. 44, 1032-1040. https://doi.org/10.3892/ijo.2014.2259
- Was, H., Borkowska, A., Olszewska, A., Klemba, A., Marciniak, M., Synowiec, A. and Kieda, C. (2022) Polyploidy formation in cancer cells: how a Trojan horse is born. Semin. Cancer Biol. 81, 24-36. https://doi.org/10.1016/j.semcancer.2021.03.003
- Weissenrieder, J. S., Neighbors, J. D., Mailman, R. B. and Hohl, R. J. (2019) Cancer and the dopamine D(2) receptor: a pharmacological perspective. J. Pharmacol. Exp. Ther. 370, 111-126. https://doi.org/10.1124/jpet.119.256818
- Wolf, K. W., Mentzel, M. and Mendoza, A. S. (1996) Treatment with the anti-tumor drugs, cis-platin and mafosfamide, does not affect the structure of prekinetochores in a human breast cancer cell line. An immunofluorescence study using human anti-centromere autoantibodies. Ann. Anat. 178, 425-432. https://doi.org/10.1016/S0940-9602(96)80132-4
- Wong, R. S. (2011) Apoptosis in cancer: from pathogenesis to treatment. J. Exp. Clin. Cancer Res. 30, 87.
- Wu, D. M., Wang, S., Wen, X., Han, X. R., Wang, Y. J., Shen, M., Fan, S. H., Zhuang, J., Zhang, Z. F., Shan, Q., Li, M. Q., Hu, B., Sun, C. H., Lu, J. and Zheng, Y. L. (2018) Inhibition of microRNA-200a upregulates the expression of striatal dopamine receptor D2 to repress apoptosis of striatum via the cAMP/PKA signaling pathway in rats with Parkinson's disease. Cell Physiol. Biochem. 51, 1600-1615. https://doi.org/10.1159/000495649
- Yin, L., Duan, J. J., Bian, X. W. and Yu, S. C. (2020) Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 22, 61.